UMIN-CTR Clinical Trial

Recruitment status Completed
Unique ID issued by UMIN UMIN000031043
Receipt No. R000035454
Official scientific title of the study Impact of tumor localization on the outcomes of surgery for an intrahepatic cholangiocarcinoma
Date of disclosure of the study information 2018/01/30
Last modified on 2018/08/01 (Ver. 3)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study Impact of tumor localization on the outcomes of surgery for an intrahepatic cholangiocarcinoma
Title of the study (Brief title) Impact of tumor localization on the outcomes of surgery for an intrahepatic cholangiocarcinoma
Region
Japan

Condition
Condition Intrahepatic cholangiocarcinoma
Classification by specialty
Hepato-biliary-pancreatic surgery
Classification by malignancy Malignancy
Genomic information NO

Objectives
Narrative objectives1 To analyze the clinicopathological features and surgical outcomes of hilar type intrahepatic cholangiocarcinoma and peripheral type intrahepatic cholangiocarcinoma.
Basic objectives2 Bio-equivalence
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes 5-year survival rate
Key secondary outcomes

Base
Study type Observational

Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
10 years-old <=
Age-upper limit
100 years-old >=
Gender Male and Female
Key inclusion criteria Intrahepatic cholangiocarcinoma patients who underwent several types of hepatectomy at the Department of Gastroenterological Surgery I at Hokkaido University Hospital between 1987 to 2017.
Key exclusion criteria Liver disease other than intrahepatic cholangiocarcinoma
Target sample size 110

Research contact person
Name of lead principal investigator Tatsuya Orimo
Organization Hokkaido University Graduate School of Medicine
Division name Department of Gastroenterological Surgery I
Address North 15-West 7, Kita-Ku, Sapporo, Hokkaido 060-8638, Japan
TEL 011-706-5927
Email tatsuori@med.hokudai.ac.jp

Public contact
Name of contact person Tatsuya Orimo
Organization Hokkaido University Graduate School of Medicine
Division name Department of Gastroenterological Surgery I
Address North 15-West 7, Kita-Ku, Sapporo, Hokkaido 060-8638, Japan
TEL 011-706-5927
Homepage URL
Email tatsuori@med.hokudai.ac.jp

Sponsor
Institute Hokkaido University Graduate School of Medicine
Institute
Department

Funding Source
Organization Hokkaido University Graduate School of Medicine
Organization
Division
Category of Funding Organization Other
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2018 Year 01 Month 30 Day

Progress
Recruitment status Completed
Date of protocol fixation
1987 Year 01 Month 01 Day
Anticipated trial start date
1987 Year 01 Month 01 Day
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Related information
URL releasing protocol
Publication of results Published
URL releasing results https://www.ncbi.nlm.nih.gov/pubmed/29721628
Results HICC shows more frequent bile duct invasion and lymph node metastasis, requires more extensive surgery, and has a higher rate of non-curative resection than PICC. However, if curative resection is achieved, the survival outcomes are expected to be equivalent between HICC and PICC.
Other related information HICC shows more frequent bile duct invasion and lymph node metastasis, requires more extensive surgery, and has a higher rate of non-curative resection than PICC. However, if curative resection is achieved, the survival outcomes are expected to be equivalent between HICC and PICC.

Management information
Registered date
2018 Year 01 Month 29 Day
Last modified on
2018 Year 08 Month 01 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000035454